Clinical Trials Directory

Trials / Completed

CompletedNCT01441427

Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
1 Month
Healthy volunteers
Not accepted

Summary

With preterm birth, the ingestion of amniotic fluid containing enterocyte trophic factors ceases abruptly. This likely predisposes them to villous atrophy feeding intolerance and necrotizing enterocolitis(NEC) once feedings are instituted.Granulocyte Colony-Stimulating Factor (G-CSF) and Erythropoietin (EPO) have important non-hematopoietic roles in human developmental biology. Among these roles, they have trophic actions on villous height and bowel length of the developing intestine.The aim of this study is to evaluate the efficacy of enteral recombinant human G-CSF and recombinant human EPO in prevention of feeding intolerance and /or NEC in preterm infants.

Conditions

Interventions

TypeNameDescription
DRUGrecombinant human G-CSF, and rhEPOG-CSF 4.5 microgram /kg/day enteral EPO 88 mIU/kg/day enteral
DRUGrh G-CSFDosage: 4.5 µg/ kg (diluted into 1 ml distilled water) administered once daily by an orogastric tube till the enteral intake reached 100 mL/kg of milk, or after a maximum of seven days.
DRUGrh EPODosage: 88 IU/ kg once daily (diluted into 1 ml distilled water) administered by an orogastric tube till the enteral intake reached 100 mL/kg of milk, or after a maximum of seven days.
DRUGrh G-GSF and rh EPO togetherEPO dosage: 88 IU/ kg once daily i.e 88000 mU/kg/day (diluted into 1 ml distilled water) administered by an orogastric tube till the enteral intake reached 100 mL/kg of milk, or after a maximum of seven days.G-CSF dosage: 4.5 µg/ kg (diluted into 1 ml distilled water) administered once daily by an orogastric tube till the enteral intake reached 100 mL/kg of milk, or after a maximum of seven days.
DRUGPlacebodistilled water :1 ml distilled water administered by an orogastric tube till the enteral intake reached 100 mL/kg of milk, or after a maximum of seven days.

Timeline

Start date
2010-01-01
Primary completion
2011-04-01
Completion
2011-08-01
First posted
2011-09-27
Last updated
2011-09-27

Source: ClinicalTrials.gov record NCT01441427. Inclusion in this directory is not an endorsement.